pubmed-article:12644723 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1267092 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0221464 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0034826 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0056693 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0030685 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1514758 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0596235 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0680255 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C0391871 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1283071 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1963578 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
pubmed-article:12644723 | lifeskim:mentions | umls-concept:C1140999 | lld:lifeskim |
pubmed-article:12644723 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12644723 | pubmed:dateCreated | 2003-3-19 | lld:pubmed |
pubmed-article:12644723 | pubmed:abstractText | The present study determined the role of cyclic ADP-ribose (cADPR) in mediating vasoconstriction and Ca(2+) release in response to the activation of muscarinic receptors. Endothelium-denuded small bovine coronary arteries were microperfused under transmural pressure of 60 mm Hg. Both acetylcholine (ACh; 1 nmol/L to 1 micromol/L) and oxotremorine (OXO; 2.5-80 micromol/L) produced a concentration-dependent contraction. The vasoconstrictor responses to both ACh and OXO were significantly attenuated by nicotinamide (Nicot; an ADP-ribosyl cyclase inhibitor), 8-bromo-cADPR (8-Br-cADPR; a cADPR antagonist) or ryanodine (Ry; an Ry receptor antagonist). Intracellular Ca(2+) ([Ca(2+)](i)) was determined by fluorescence spectrometry using fura-2 as a fluorescence indicator. OXO produced a rapid increase in [Ca(2+)](i) in freshly isolated single coronary arterial smooth muscle cells (CASMCs) bathed with Ca(2+)-free Hanks' solution. This OXO-induced rise in [Ca(2+)](i) was significantly reduced by pirenzepine (PIR; an M(1) receptor-specific blocker), Nicot, 8-Br-cADPR or Ry. The effects of OXO on the activity of ADP-ribosyl cyclase (cADPR synthase) were examined in cultured CASMCs by measuring the rate of cyclic GDP- ribose (cGDPR) formation from beta-nicotinamide guanine dinucleotide. It was found that OXO produced a concentration-dependent increase in the production of cGDPR. The stimulatory effect of OXO on ADP-ribosyl cyclase was inhibited by both PIR and Nicot. These results suggest that the cADPR signaling pathway participates in the contraction of small coronary arterial smooth muscle and Ca(2+) release induced by activation of M(1) muscarinic receptors. | lld:pubmed |
pubmed-article:12644723 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:language | eng | lld:pubmed |
pubmed-article:12644723 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12644723 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12644723 | pubmed:issn | 1018-1172 | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:CampbellWilli... | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:ZouAi-PingAP | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:ChenYa-FeiYF | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:LiPin-LanPL | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:ZhangDavid... | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:GeZhi-DongZD | lld:pubmed |
pubmed-article:12644723 | pubmed:author | pubmed-author:YiFu-XianFX | lld:pubmed |
pubmed-article:12644723 | pubmed:copyrightInfo | Copyright 2003 S. Karger AG, Basel | lld:pubmed |
pubmed-article:12644723 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12644723 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:12644723 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12644723 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12644723 | pubmed:pagination | 28-36 | lld:pubmed |
pubmed-article:12644723 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:meshHeading | pubmed-meshheading:12644723... | lld:pubmed |
pubmed-article:12644723 | pubmed:articleTitle | Cyclic ADP-ribose contributes to contraction and Ca2+ release by M1 muscarinic receptor activation in coronary arterial smooth muscle. | lld:pubmed |
pubmed-article:12644723 | pubmed:affiliation | Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226, USA. | lld:pubmed |
pubmed-article:12644723 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12644723 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12644723 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:281684 | entrezgene:pubmed | pubmed-article:12644723 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12644723 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12644723 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12644723 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12644723 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12644723 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12644723 | lld:pubmed |